instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'BORTEZOMIB'? | Successful ixazomib treatment for relapsed and refractory acute myeloid leukemia transformed from myelodysplastic syndrome.
Elevated NF-kB levels have been identified in primitive bone marrow cells from patients with MDS/AML, suggesting NF-kB as a therapeutic target in MDS/AML. We herein describe an MDS patient ineligi... | 1.3 MILLIGRAM/SQ. METER | DrugDosageText | CC BY | 34194792 | 19,575,818 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colitis'. | Rhizopus microsporus typhlitis in a patient with acute myelogenous leukemia.
While patients undergoing treatment for hematologic malignancies are at risk for a variety of infections, gastrointestinal mucormycosis is a rare and feared complication. Diagnosis requires a high index of suspicion and timely evaluation. Prom... | ACYCLOVIR, CEFEPIME HYDROCHLORIDE, CYTARABINE, DAUNORUBICIN, MICAFUNGIN SODIUM | DrugsGivenReaction | CC BY-NC | 34194794 | 19,883,703 | 2021-06 |
What was the dosage of drug 'ACYCLOVIR'? | Rhizopus microsporus typhlitis in a patient with acute myelogenous leukemia.
While patients undergoing treatment for hematologic malignancies are at risk for a variety of infections, gastrointestinal mucormycosis is a rare and feared complication. Diagnosis requires a high index of suspicion and timely evaluation. Prom... | UNKNOWN | DrugDosageText | CC BY-NC | 34194794 | 19,883,703 | 2021-06 |
What was the dosage of drug 'CEFEPIME HYDROCHLORIDE'? | Rhizopus microsporus typhlitis in a patient with acute myelogenous leukemia.
While patients undergoing treatment for hematologic malignancies are at risk for a variety of infections, gastrointestinal mucormycosis is a rare and feared complication. Diagnosis requires a high index of suspicion and timely evaluation. Prom... | UNKNOWN | DrugDosageText | CC BY-NC | 34194794 | 19,883,703 | 2021-06 |
What was the dosage of drug 'CYTARABINE'? | Rhizopus microsporus typhlitis in a patient with acute myelogenous leukemia.
While patients undergoing treatment for hematologic malignancies are at risk for a variety of infections, gastrointestinal mucormycosis is a rare and feared complication. Diagnosis requires a high index of suspicion and timely evaluation. Prom... | UNKNOWN | DrugDosageText | CC BY-NC | 34194794 | 19,883,703 | 2021-06 |
What was the dosage of drug 'DAUNORUBICIN'? | Rhizopus microsporus typhlitis in a patient with acute myelogenous leukemia.
While patients undergoing treatment for hematologic malignancies are at risk for a variety of infections, gastrointestinal mucormycosis is a rare and feared complication. Diagnosis requires a high index of suspicion and timely evaluation. Prom... | UNKNOWN | DrugDosageText | CC BY-NC | 34194794 | 19,883,703 | 2021-06 |
What was the dosage of drug 'MICAFUNGIN SODIUM'? | Rhizopus microsporus typhlitis in a patient with acute myelogenous leukemia.
While patients undergoing treatment for hematologic malignancies are at risk for a variety of infections, gastrointestinal mucormycosis is a rare and feared complication. Diagnosis requires a high index of suspicion and timely evaluation. Prom... | UNKNOWN | DrugDosageText | CC BY-NC | 34194794 | 19,883,703 | 2021-06 |
What was the outcome of reaction 'Colitis'? | Rhizopus microsporus typhlitis in a patient with acute myelogenous leukemia.
While patients undergoing treatment for hematologic malignancies are at risk for a variety of infections, gastrointestinal mucormycosis is a rare and feared complication. Diagnosis requires a high index of suspicion and timely evaluation. Prom... | Recovering | ReactionOutcome | CC BY-NC | 34194794 | 19,883,703 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Agranulocytosis'. | Diagnostics of Torsade de Pointes in an oncohematology patient: A case report.
Complex heart rhythm disturbances due to cardiotoxicity may not be identified in time, and this may have an unfavorable outcome for patients. Holter monitoring can be a solution to prevent sudden cardiac death of oncohematology patients.
1 I... | CYCLOPHOSPHAMIDE, CYTARABINE, DAUNORUBICIN, DEXAMETHASONE, DOXORUBICIN HYDROCHLORIDE, MERCAPTOPURINE | DrugsGivenReaction | CC BY | 34194796 | 19,818,004 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bronchopulmonary aspergillosis'. | Diagnostics of Torsade de Pointes in an oncohematology patient: A case report.
Complex heart rhythm disturbances due to cardiotoxicity may not be identified in time, and this may have an unfavorable outcome for patients. Holter monitoring can be a solution to prevent sudden cardiac death of oncohematology patients.
1 I... | CYCLOPHOSPHAMIDE, CYTARABINE, DAUNORUBICIN, DEXAMETHASONE, DOXORUBICIN HYDROCHLORIDE, MERCAPTOPURINE | DrugsGivenReaction | CC BY | 34194796 | 19,818,004 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Diagnostics of Torsade de Pointes in an oncohematology patient: A case report.
Complex heart rhythm disturbances due to cardiotoxicity may not be identified in time, and this may have an unfavorable outcome for patients. Holter monitoring can be a solution to prevent sudden cardiac death of oncohematology patients.
1 I... | CYCLOPHOSPHAMIDE, CYTARABINE, DAUNORUBICIN, DEXAMETHASONE, DOXORUBICIN HYDROCHLORIDE, MERCAPTOPURINE | DrugsGivenReaction | CC BY | 34194796 | 19,818,004 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Staphylococcal sepsis'. | Diagnostics of Torsade de Pointes in an oncohematology patient: A case report.
Complex heart rhythm disturbances due to cardiotoxicity may not be identified in time, and this may have an unfavorable outcome for patients. Holter monitoring can be a solution to prevent sudden cardiac death of oncohematology patients.
1 I... | CYCLOPHOSPHAMIDE, CYTARABINE, DAUNORUBICIN, DEXAMETHASONE, DOXORUBICIN HYDROCHLORIDE, MERCAPTOPURINE | DrugsGivenReaction | CC BY | 34194796 | 19,818,004 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Torsade de pointes'. | Diagnostics of Torsade de Pointes in an oncohematology patient: A case report.
Complex heart rhythm disturbances due to cardiotoxicity may not be identified in time, and this may have an unfavorable outcome for patients. Holter monitoring can be a solution to prevent sudden cardiac death of oncohematology patients.
1 I... | CYCLOPHOSPHAMIDE, CYTARABINE, DAUNORUBICIN, DEXAMETHASONE, DOXORUBICIN HYDROCHLORIDE, MERCAPTOPURINE | DrugsGivenReaction | CC BY | 34194796 | 19,818,004 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ventricular fibrillation'. | Diagnostics of Torsade de Pointes in an oncohematology patient: A case report.
Complex heart rhythm disturbances due to cardiotoxicity may not be identified in time, and this may have an unfavorable outcome for patients. Holter monitoring can be a solution to prevent sudden cardiac death of oncohematology patients.
1 I... | CYCLOPHOSPHAMIDE, CYTARABINE, DAUNORUBICIN, DEXAMETHASONE, DOXORUBICIN HYDROCHLORIDE, MERCAPTOPURINE | DrugsGivenReaction | CC BY | 34194796 | 19,818,004 | 2021-06 |
What was the outcome of reaction 'Torsade de pointes'? | Diagnostics of Torsade de Pointes in an oncohematology patient: A case report.
Complex heart rhythm disturbances due to cardiotoxicity may not be identified in time, and this may have an unfavorable outcome for patients. Holter monitoring can be a solution to prevent sudden cardiac death of oncohematology patients.
1 I... | Recovered | ReactionOutcome | CC BY | 34194796 | 19,818,004 | 2021-06 |
What was the outcome of reaction 'Ventricular fibrillation'? | Diagnostics of Torsade de Pointes in an oncohematology patient: A case report.
Complex heart rhythm disturbances due to cardiotoxicity may not be identified in time, and this may have an unfavorable outcome for patients. Holter monitoring can be a solution to prevent sudden cardiac death of oncohematology patients.
1 I... | Recovered | ReactionOutcome | CC BY | 34194796 | 19,818,004 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | SARS-CoV-2 infection as a potential triggering factor for urticarial vasculitis during pregnancy: A case report.
During the COVID-19 pandemic, physicians must maintain a high index of suspicion for COVID-19 in cases of urticarial vasculitis or other forms of urticaria. This is particularly important for acute presentat... | ACETAMINOPHEN, CETIRIZINE HYDROCHLORIDE, HEPARIN SODIUM, IRON, VITAMINS | DrugsGivenReaction | CC BY | 34194805 | 20,163,452 | 2021-06 |
What was the administration route of drug 'HEPARIN SODIUM'? | SARS-CoV-2 infection as a potential triggering factor for urticarial vasculitis during pregnancy: A case report.
During the COVID-19 pandemic, physicians must maintain a high index of suspicion for COVID-19 in cases of urticarial vasculitis or other forms of urticaria. This is particularly important for acute presentat... | Subcutaneous | DrugAdministrationRoute | CC BY | 34194805 | 20,163,452 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Type 1 lepra reaction'. | Rare occurrence of lepra type 1 reaction in pure neuritic leprosy: A case report.
Type 1 reaction in pure neuritic leprosy usually occurs in the form of neuritis. The development of new skin lesion during reaction is rare. Clinicians should be aware about occurrence of type 1 reaction in pure neuritic leprosy.
1 INTROD... | CLOFAZIMINE, DAPSONE, RIFAMPIN | DrugsGivenReaction | CC BY | 34194806 | 20,389,091 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Type IV hypersensitivity reaction'. | Rare occurrence of lepra type 1 reaction in pure neuritic leprosy: A case report.
Type 1 reaction in pure neuritic leprosy usually occurs in the form of neuritis. The development of new skin lesion during reaction is rare. Clinicians should be aware about occurrence of type 1 reaction in pure neuritic leprosy.
1 INTROD... | CLOFAZIMINE, DAPSONE, RIFAMPIN | DrugsGivenReaction | CC BY | 34194806 | 20,389,091 | 2021-06 |
What was the dosage of drug 'DAPSONE'? | Rare occurrence of lepra type 1 reaction in pure neuritic leprosy: A case report.
Type 1 reaction in pure neuritic leprosy usually occurs in the form of neuritis. The development of new skin lesion during reaction is rare. Clinicians should be aware about occurrence of type 1 reaction in pure neuritic leprosy.
1 INTROD... | 1 DOSAGE FORM, QD (ON DAY 1-28) | DrugDosageText | CC BY | 34194806 | 20,389,091 | 2021-06 |
What was the dosage of drug 'RIFAMPIN'? | Rare occurrence of lepra type 1 reaction in pure neuritic leprosy: A case report.
Type 1 reaction in pure neuritic leprosy usually occurs in the form of neuritis. The development of new skin lesion during reaction is rare. Clinicians should be aware about occurrence of type 1 reaction in pure neuritic leprosy.
1 INTROD... | 2 DOSAGE FORM (CAPSULE); ON DAY 1, STRENGTH 300 MG | DrugDosageText | CC BY | 34194806 | 20,389,091 | 2021-06 |
What was the outcome of reaction 'Type 1 lepra reaction'? | Rare occurrence of lepra type 1 reaction in pure neuritic leprosy: A case report.
Type 1 reaction in pure neuritic leprosy usually occurs in the form of neuritis. The development of new skin lesion during reaction is rare. Clinicians should be aware about occurrence of type 1 reaction in pure neuritic leprosy.
1 INTROD... | Recovered | ReactionOutcome | CC BY | 34194806 | 20,389,091 | 2021-06 |
What was the outcome of reaction 'Type IV hypersensitivity reaction'? | Rare occurrence of lepra type 1 reaction in pure neuritic leprosy: A case report.
Type 1 reaction in pure neuritic leprosy usually occurs in the form of neuritis. The development of new skin lesion during reaction is rare. Clinicians should be aware about occurrence of type 1 reaction in pure neuritic leprosy.
1 INTROD... | Recovered | ReactionOutcome | CC BY | 34194806 | 20,389,091 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Re-exposure to immunotherapy in metastatic colon cancer: A case report.
Re-exposure to immunotherapy in metastatic colorectal cancer may be indicated in selected patients that previously benefitted from immunotherapy with tolerable irAEs.
1 INTRODUCTION
Patients with metastatic colorectal cancer characterized by a def... | BEVACIZUMAB, FLUOROURACIL, IPILIMUMAB, IRINOTECAN, NIVOLUMAB | DrugsGivenReaction | CC BY-NC | 34194811 | 19,985,790 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Re-exposure to immunotherapy in metastatic colon cancer: A case report.
Re-exposure to immunotherapy in metastatic colorectal cancer may be indicated in selected patients that previously benefitted from immunotherapy with tolerable irAEs.
1 INTRODUCTION
Patients with metastatic colorectal cancer characterized by a def... | BEVACIZUMAB, FLUOROURACIL, IPILIMUMAB, IRINOTECAN, NIVOLUMAB | DrugsGivenReaction | CC BY-NC | 34194811 | 19,985,790 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Neuromyelitis optica with rapid respiratory failure: a case report.
Neuromyelitis optica is an inflammatory demyelinating disease of the central nervous system and is characterized by severe optic neuritis and transverse myelitis.
The patient was a 74-year-old man with pneumonia. On admission, he exhibited lower limb w... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34194814 | 20,807,064 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Neuromyelitis optica with rapid respiratory failure: a case report.
Neuromyelitis optica is an inflammatory demyelinating disease of the central nervous system and is characterized by severe optic neuritis and transverse myelitis.
The patient was a 74-year-old man with pneumonia. On admission, he exhibited lower limb w... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34194814 | 20,807,064 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peripheral swelling'. | Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?
Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-ind... | ANAKINRA, HYDROCORTISONE | DrugsGivenReaction | CC BY | 34194852 | 19,598,162 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Platelet count decreased'. | Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?
Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-ind... | ANAKINRA, HYDROCORTISONE | DrugsGivenReaction | CC BY | 34194852 | 19,598,162 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombosis'. | Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?
Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-ind... | ANAKINRA, HYDROCORTISONE | DrugsGivenReaction | CC BY | 34194852 | 19,598,162 | 2021 |
What was the outcome of reaction 'Platelet count decreased'? | Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?
Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-ind... | Recovered | ReactionOutcome | CC BY | 34194852 | 19,598,162 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cutaneous vasculitis'. | The Many Faces of Purpura: Vancomycin-Induced Leukocytoclastic Vasculitis.
Leukocytoclastic vasculitis is a rare form of immune-mediated vasculitis that might be caused by infections or autoimmune diseases or might be precipitated by specific medications. We describe a 65-year-old patient, who was receiving vancomycin ... | VANCOMYCIN | DrugsGivenReaction | CC BY | 34194855 | 19,566,397 | 2021 |
What was the administration route of drug 'VANCOMYCIN'? | The Many Faces of Purpura: Vancomycin-Induced Leukocytoclastic Vasculitis.
Leukocytoclastic vasculitis is a rare form of immune-mediated vasculitis that might be caused by infections or autoimmune diseases or might be precipitated by specific medications. We describe a 65-year-old patient, who was receiving vancomycin ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34194855 | 19,566,397 | 2021 |
What was the dosage of drug 'VANCOMYCIN'? | The Many Faces of Purpura: Vancomycin-Induced Leukocytoclastic Vasculitis.
Leukocytoclastic vasculitis is a rare form of immune-mediated vasculitis that might be caused by infections or autoimmune diseases or might be precipitated by specific medications. We describe a 65-year-old patient, who was receiving vancomycin ... | THRICE WEEKLY | DrugDosageText | CC BY | 34194855 | 19,566,397 | 2021 |
What was the outcome of reaction 'Cutaneous vasculitis'? | The Many Faces of Purpura: Vancomycin-Induced Leukocytoclastic Vasculitis.
Leukocytoclastic vasculitis is a rare form of immune-mediated vasculitis that might be caused by infections or autoimmune diseases or might be precipitated by specific medications. We describe a 65-year-old patient, who was receiving vancomycin ... | Recovered | ReactionOutcome | CC BY | 34194855 | 19,566,397 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Borderline serous tumour of ovary'. | Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer.
Ovarian cancer is the most fatal gynecologic malignancy. The incidence of ovarian cancer among female-to-male transsexuals receiving treatment with testosterone is unknown, and few cases have b... | BUDESONIDE\FORMOTEROL FUMARATE, CETIRIZINE HYDROCHLORIDE, TESTOSTERONE UNDECANOATE | DrugsGivenReaction | CC BY | 34194862 | 19,635,919 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer.
Ovarian cancer is the most fatal gynecologic malignancy. The incidence of ovarian cancer among female-to-male transsexuals receiving treatment with testosterone is unknown, and few cases have b... | BUDESONIDE\FORMOTEROL FUMARATE, CETIRIZINE HYDROCHLORIDE, TESTOSTERONE UNDECANOATE | DrugsGivenReaction | CC BY | 34194862 | 19,635,919 | 2021 |
What was the dosage of drug 'BUDESONIDE\FORMOTEROL FUMARATE'? | Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer.
Ovarian cancer is the most fatal gynecologic malignancy. The incidence of ovarian cancer among female-to-male transsexuals receiving treatment with testosterone is unknown, and few cases have b... | UNK UNKNOWN, UNKNOWN | DrugDosageText | CC BY | 34194862 | 19,635,919 | 2021 |
What was the dosage of drug 'CETIRIZINE HYDROCHLORIDE'? | Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer.
Ovarian cancer is the most fatal gynecologic malignancy. The incidence of ovarian cancer among female-to-male transsexuals receiving treatment with testosterone is unknown, and few cases have b... | UNK UNKNOWN, UNKNOWN | DrugDosageText | CC BY | 34194862 | 19,635,919 | 2021 |
What was the dosage of drug 'TESTOSTERONE UNDECANOATE'? | Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer.
Ovarian cancer is the most fatal gynecologic malignancy. The incidence of ovarian cancer among female-to-male transsexuals receiving treatment with testosterone is unknown, and few cases have b... | UNK UNKNOWN, UNKNOWN | DrugDosageText | CC BY | 34194862 | 19,635,919 | 2021 |
What was the outcome of reaction 'Borderline serous tumour of ovary'? | Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer.
Ovarian cancer is the most fatal gynecologic malignancy. The incidence of ovarian cancer among female-to-male transsexuals receiving treatment with testosterone is unknown, and few cases have b... | Recovered | ReactionOutcome | CC BY | 34194862 | 19,635,919 | 2021 |
What was the outcome of reaction 'Off label use'? | Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer.
Ovarian cancer is the most fatal gynecologic malignancy. The incidence of ovarian cancer among female-to-male transsexuals receiving treatment with testosterone is unknown, and few cases have b... | Recovered | ReactionOutcome | CC BY | 34194862 | 19,635,919 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Potent efficacy of chlorpromazine in acute myeloid leukemia harboring KIT-D816V mutation.
Acute myeloid leukemia (AML) is a heterogeneous disease often associated with poor prognosis. We previously showed that the localization of KIT-D816V at endolysosomes is critical to activate aberrant Akt signaling and Chlorpromazi... | CHLORPROMAZINE | DrugsGivenReaction | CC BY-NC-ND | 34194969 | 20,452,669 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Somnolence'. | Potent efficacy of chlorpromazine in acute myeloid leukemia harboring KIT-D816V mutation.
Acute myeloid leukemia (AML) is a heterogeneous disease often associated with poor prognosis. We previously showed that the localization of KIT-D816V at endolysosomes is critical to activate aberrant Akt signaling and Chlorpromazi... | CHLORPROMAZINE | DrugsGivenReaction | CC BY-NC-ND | 34194969 | 20,452,669 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic response unexpected'. | Potent efficacy of chlorpromazine in acute myeloid leukemia harboring KIT-D816V mutation.
Acute myeloid leukemia (AML) is a heterogeneous disease often associated with poor prognosis. We previously showed that the localization of KIT-D816V at endolysosomes is critical to activate aberrant Akt signaling and Chlorpromazi... | CHLORPROMAZINE | DrugsGivenReaction | CC BY-NC-ND | 34194969 | 20,452,669 | 2021 |
What was the outcome of reaction 'Somnolence'? | Potent efficacy of chlorpromazine in acute myeloid leukemia harboring KIT-D816V mutation.
Acute myeloid leukemia (AML) is a heterogeneous disease often associated with poor prognosis. We previously showed that the localization of KIT-D816V at endolysosomes is critical to activate aberrant Akt signaling and Chlorpromazi... | Recovering | ReactionOutcome | CC BY-NC-ND | 34194969 | 20,452,669 | 2021 |
What was the dosage of drug 'AMOXICILLIN'? | A rare case of recurrent HHV6 encephalitis in an immunocompetent adult.
Human Herpesvirus 6 (HHV-6) is a virus known to cause mild infection in children. In adults, HHV-6 reactivation has been described in immunocompromised individuals.Rarely, viral reactivation occurs in immunocompetent adults causing significant dise... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34195000 | 19,602,635 | 2021 |
What was the outcome of reaction 'Human herpesvirus 6 encephalitis'? | A rare case of recurrent HHV6 encephalitis in an immunocompetent adult.
Human Herpesvirus 6 (HHV-6) is a virus known to cause mild infection in children. In adults, HHV-6 reactivation has been described in immunocompromised individuals.Rarely, viral reactivation occurs in immunocompetent adults causing significant dise... | Recovered | ReactionOutcome | CC BY-NC-ND | 34195000 | 19,606,434 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Corneal opacity'. | A case of infectious crystalline keratopathy after corneal cross-linking.
To present a case of infectious crystalline keratopathy after corneal cross-linking in a child with delayed wound healing, and its successful management with antibiotic and anti-fungal eye drops.
A 14-year-old male presented for a second opinion ... | DIFLUPREDNATE, RIBOFLAVIN 5^-PHOSPHATE SODIUM, TOBRAMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34195474 | 19,630,758 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eye pain'. | A case of infectious crystalline keratopathy after corneal cross-linking.
To present a case of infectious crystalline keratopathy after corneal cross-linking in a child with delayed wound healing, and its successful management with antibiotic and anti-fungal eye drops.
A 14-year-old male presented for a second opinion ... | DIFLUPREDNATE, RIBOFLAVIN 5^-PHOSPHATE SODIUM, TOBRAMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34195474 | 19,630,758 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Impaired healing'. | A case of infectious crystalline keratopathy after corneal cross-linking.
To present a case of infectious crystalline keratopathy after corneal cross-linking in a child with delayed wound healing, and its successful management with antibiotic and anti-fungal eye drops.
A 14-year-old male presented for a second opinion ... | DIFLUPREDNATE, RIBOFLAVIN 5^-PHOSPHATE SODIUM, TOBRAMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34195474 | 19,630,758 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ocular hyperaemia'. | A case of infectious crystalline keratopathy after corneal cross-linking.
To present a case of infectious crystalline keratopathy after corneal cross-linking in a child with delayed wound healing, and its successful management with antibiotic and anti-fungal eye drops.
A 14-year-old male presented for a second opinion ... | DIFLUPREDNATE, RIBOFLAVIN 5^-PHOSPHATE SODIUM, TOBRAMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34195474 | 19,630,758 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Visual acuity reduced'. | A case of infectious crystalline keratopathy after corneal cross-linking.
To present a case of infectious crystalline keratopathy after corneal cross-linking in a child with delayed wound healing, and its successful management with antibiotic and anti-fungal eye drops.
A 14-year-old male presented for a second opinion ... | DIFLUPREDNATE, RIBOFLAVIN 5^-PHOSPHATE SODIUM, TOBRAMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34195474 | 19,630,758 | 2021-09 |
What was the administration route of drug 'RIBOFLAVIN 5^-PHOSPHATE SODIUM'? | A case of infectious crystalline keratopathy after corneal cross-linking.
To present a case of infectious crystalline keratopathy after corneal cross-linking in a child with delayed wound healing, and its successful management with antibiotic and anti-fungal eye drops.
A 14-year-old male presented for a second opinion ... | Ophthalmic | DrugAdministrationRoute | CC BY-NC-ND | 34195474 | 19,630,758 | 2021-09 |
What was the administration route of drug 'TOBRAMYCIN'? | A case of infectious crystalline keratopathy after corneal cross-linking.
To present a case of infectious crystalline keratopathy after corneal cross-linking in a child with delayed wound healing, and its successful management with antibiotic and anti-fungal eye drops.
A 14-year-old male presented for a second opinion ... | Ophthalmic | DrugAdministrationRoute | CC BY-NC-ND | 34195474 | 19,630,758 | 2021-09 |
What was the outcome of reaction 'Corneal opacity'? | A case of infectious crystalline keratopathy after corneal cross-linking.
To present a case of infectious crystalline keratopathy after corneal cross-linking in a child with delayed wound healing, and its successful management with antibiotic and anti-fungal eye drops.
A 14-year-old male presented for a second opinion ... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34195474 | 19,630,758 | 2021-09 |
What was the outcome of reaction 'Eye pain'? | A case of infectious crystalline keratopathy after corneal cross-linking.
To present a case of infectious crystalline keratopathy after corneal cross-linking in a child with delayed wound healing, and its successful management with antibiotic and anti-fungal eye drops.
A 14-year-old male presented for a second opinion ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34195474 | 19,630,758 | 2021-09 |
What was the outcome of reaction 'Impaired healing'? | A case of infectious crystalline keratopathy after corneal cross-linking.
To present a case of infectious crystalline keratopathy after corneal cross-linking in a child with delayed wound healing, and its successful management with antibiotic and anti-fungal eye drops.
A 14-year-old male presented for a second opinion ... | Recovering | ReactionOutcome | CC BY-NC-ND | 34195474 | 19,630,758 | 2021-09 |
What was the outcome of reaction 'Ocular hyperaemia'? | A case of infectious crystalline keratopathy after corneal cross-linking.
To present a case of infectious crystalline keratopathy after corneal cross-linking in a child with delayed wound healing, and its successful management with antibiotic and anti-fungal eye drops.
A 14-year-old male presented for a second opinion ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34195474 | 19,630,758 | 2021-09 |
What was the outcome of reaction 'Visual acuity reduced'? | A case of infectious crystalline keratopathy after corneal cross-linking.
To present a case of infectious crystalline keratopathy after corneal cross-linking in a child with delayed wound healing, and its successful management with antibiotic and anti-fungal eye drops.
A 14-year-old male presented for a second opinion ... | Recovering | ReactionOutcome | CC BY-NC-ND | 34195474 | 19,630,758 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Deep vein thrombosis'. | Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction.
Although capillary leak syndrome has a high mortality rate, its trigger, diagnosis, and treatment remain a challenge to clinicians because of the poor understanding of its mechanism and lack of treatment gu... | ALBUMIN HUMAN, AMILORIDE, AXITINIB, BEVACIZUMAB, BUMETANIDE, FUROSEMIDE, MIDODRINE, OCTREOTIDE, PEMBROLIZUMAB, TALIMOGENE LAHERPAREPVEC, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34195558 | 20,727,542 | 2021-06 |
What was the administration route of drug 'FUROSEMIDE'? | Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction.
Although capillary leak syndrome has a high mortality rate, its trigger, diagnosis, and treatment remain a challenge to clinicians because of the poor understanding of its mechanism and lack of treatment gu... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34195558 | 20,727,542 | 2021-06 |
What was the administration route of drug 'MIDODRINE'? | Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction.
Although capillary leak syndrome has a high mortality rate, its trigger, diagnosis, and treatment remain a challenge to clinicians because of the poor understanding of its mechanism and lack of treatment gu... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34195558 | 20,727,542 | 2021-06 |
What was the dosage of drug 'AXITINIB'? | Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction.
Although capillary leak syndrome has a high mortality rate, its trigger, diagnosis, and treatment remain a challenge to clinicians because of the poor understanding of its mechanism and lack of treatment gu... | 5 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34195558 | 20,727,542 | 2021-06 |
What was the dosage of drug 'FUROSEMIDE'? | Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction.
Although capillary leak syndrome has a high mortality rate, its trigger, diagnosis, and treatment remain a challenge to clinicians because of the poor understanding of its mechanism and lack of treatment gu... | 40 TO 80 MG/D | DrugDosageText | CC BY-NC-ND | 34195558 | 20,727,542 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | PEMBROLIZUMAB, RITUXIMAB | DrugsGivenReaction | CC BY | 34196768 | 20,575,978 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34196768 | 19,582,850 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | PEMBROLIZUMAB, RITUXIMAB | DrugsGivenReaction | CC BY | 34196768 | 20,575,978 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | PEMBROLIZUMAB, RITUXIMAB | DrugsGivenReaction | CC BY | 34196768 | 20,575,978 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | BUDESONIDE, HUMAN IMMUNOGLOBULIN G, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34196768 | 20,472,719 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | BUDESONIDE, HUMAN IMMUNOGLOBULIN G, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34196768 | 20,474,688 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hemianopia'. | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | PEMBROLIZUMAB, RITUXIMAB | DrugsGivenReaction | CC BY | 34196768 | 20,575,978 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune reconstitution inflammatory syndrome'. | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | BUDESONIDE, HUMAN IMMUNOGLOBULIN G, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34196768 | 20,514,735 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune thrombocytopenia'. | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | BUDESONIDE, HUMAN IMMUNOGLOBULIN G, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34196768 | 20,514,735 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated hepatitis'. | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34196768 | 19,582,850 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Iris cyst'. | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | PEMBROLIZUMAB, RITUXIMAB | DrugsGivenReaction | CC BY | 34196768 | 20,575,978 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukopenia'. | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34196768 | 19,582,850 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphoma'. | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | PEMBROLIZUMAB, RITUXIMAB | DrugsGivenReaction | CC BY | 34196768 | 20,575,978 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancytopenia'. | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34196768 | 19,582,850 | 2021-07-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34196768 | 19,582,850 | 2021-07-01 |
What was the outcome of reaction 'Death'? | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | Fatal | ReactionOutcome | CC BY | 34196768 | 20,575,978 | 2021-07-01 |
What was the outcome of reaction 'Disease progression'? | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | Fatal | ReactionOutcome | CC BY | 34196768 | 20,628,233 | 2021-07-01 |
What was the outcome of reaction 'Disease recurrence'? | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | Fatal | ReactionOutcome | CC BY | 34196768 | 20,628,233 | 2021-07-01 |
What was the outcome of reaction 'Drug ineffective for unapproved indication'? | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | Fatal | ReactionOutcome | CC BY | 34196768 | 20,472,719 | 2021-07-01 |
What was the outcome of reaction 'Drug ineffective'? | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | Fatal | ReactionOutcome | CC BY | 34196768 | 20,474,688 | 2021-07-01 |
What was the outcome of reaction 'Haemorrhage'? | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | Fatal | ReactionOutcome | CC BY | 34196768 | 19,582,850 | 2021-07-01 |
What was the outcome of reaction 'Hemianopia'? | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | Fatal | ReactionOutcome | CC BY | 34196768 | 20,628,233 | 2021-07-01 |
What was the outcome of reaction 'Immune reconstitution inflammatory syndrome'? | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | Fatal | ReactionOutcome | CC BY | 34196768 | 20,514,735 | 2021-07-01 |
What was the outcome of reaction 'Immune thrombocytopenia'? | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | Fatal | ReactionOutcome | CC BY | 34196768 | 20,514,735 | 2021-07-01 |
What was the outcome of reaction 'Iris cyst'? | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | Fatal | ReactionOutcome | CC BY | 34196768 | 20,628,233 | 2021-07-01 |
What was the outcome of reaction 'Lymphoma'? | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | Fatal | ReactionOutcome | CC BY | 34196768 | 20,628,233 | 2021-07-01 |
What was the outcome of reaction 'Progressive multifocal leukoencephalopathy'? | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | Fatal | ReactionOutcome | CC BY | 34196768 | 20,499,281 | 2021-07-01 |
What was the outcome of reaction 'Thrombocytopenia'? | Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Progressive multifocal leukoencephalopathy is a rare opportunistic infection of the brain by John Cunningham polyomavirus in immune-compromised patients. I... | Fatal | ReactionOutcome | CC BY | 34196768 | 19,582,850 | 2021-07-01 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Active Herpes Zoster Mimicking Worsening of Axillary Lymph Node Metastases of Breast Cancer after Chemotherapy on 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography.
A woman in her 60s presented to our hospital with a left breast mass that was diagnosed as breast cancer. 18F-Fluorodeoxyglucose posi... | FOUR CYCLES | DrugDosageText | CC BY | 34198598 | 19,932,509 | 2021-06-14 |
What was the dosage of drug 'DOXORUBICIN HYDROCHLORIDE'? | Active Herpes Zoster Mimicking Worsening of Axillary Lymph Node Metastases of Breast Cancer after Chemotherapy on 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography.
A woman in her 60s presented to our hospital with a left breast mass that was diagnosed as breast cancer. 18F-Fluorodeoxyglucose posi... | 11 CYCLES | DrugDosageText | CC BY | 34198598 | 19,932,509 | 2021-06-14 |
What was the dosage of drug 'PACLITAXEL'? | Active Herpes Zoster Mimicking Worsening of Axillary Lymph Node Metastases of Breast Cancer after Chemotherapy on 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography.
A woman in her 60s presented to our hospital with a left breast mass that was diagnosed as breast cancer. 18F-Fluorodeoxyglucose posi... | FOUR CYCLES | DrugDosageText | CC BY | 34198598 | 19,932,509 | 2021-06-14 |
What was the outcome of reaction 'Herpes zoster'? | Active Herpes Zoster Mimicking Worsening of Axillary Lymph Node Metastases of Breast Cancer after Chemotherapy on 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography.
A woman in her 60s presented to our hospital with a left breast mass that was diagnosed as breast cancer. 18F-Fluorodeoxyglucose posi... | Recovered | ReactionOutcome | CC BY | 34198598 | 19,952,898 | 2021-06-14 |
What was the administration route of drug 'FLUOROURACIL'? | Clinical Outcomes of Conversion Surgery after FOLFIRINOX in Patients with Unresectable Advanced Pancreatic Cancer: A Retrospective Cohort Study at a Single Center.
Pancreatic cancer is one of the most lethal cancers. To improve its prognosis, conversion surgery for initially unresectable advanced pancreatic cancer (UAP... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34199125 | 20,111,369 | 2021-06-27 |
What was the administration route of drug 'IRINOTECAN HYDROCHLORIDE'? | Clinical Outcomes of Conversion Surgery after FOLFIRINOX in Patients with Unresectable Advanced Pancreatic Cancer: A Retrospective Cohort Study at a Single Center.
Pancreatic cancer is one of the most lethal cancers. To improve its prognosis, conversion surgery for initially unresectable advanced pancreatic cancer (UAP... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34199125 | 19,998,872 | 2021-06-27 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.